This study is only available for people able to travel to our office in Duncraig, WA 6023

Long COVID or post-COVID-19 syndrome is when people experience continued symptoms for longer than 12 weeks after their initial COVID-19 infection. Long COVID is associated with a range of mental and physical symptoms, with common symptoms including fatigue, shortness of breath, heart palpitations, chest pain or tightness, light-headedness, brain fog, and loss of taste/ smell.

SRS-MHT-44 is a liquid herbal formula containing more than 30 herbal ingredients that have been shown to influence immune function. Some of these ingredients include curcumin, ashwagandha, ginseng, and ginkgo biloba. In this study, we are interested in examining the effects of SRS-MHT-44 in improving quality of life and symptoms associated with long COVID.

There is no cost for participating in this study. There is no cost for participating in this study. To compensate you for your time and travel costs, you will be given a $40 Coles group gift voucher at visits 1 and 2, and a $60 voucher at visit 3.

If you are between 18 and 65 years old and believe you suffer from long COVID, we invite you to participate in this randomised, controlled study.

Eligible participants will be RANDOMLY allocated into ONE of TWO treatment conditions:

1. Daily intake of SRS-MHT-44 (15mls, three times daily), or
2. Daily intake of a placebo (fake) liquid formula
   

To be INCLUDED in the study, the following inclusion criteria must be met:

1. You are aged between 18 to 65 years
2. You have a body mass index (BMI) between 18.5 and 30 kg/m2
3. You suffered from a COVID-19 infection at least 3 months ago, and this was confirmed by a rapid antigen or PCR test
4. You suffer from long COVID. Long COVID is the continual experience of a range of physical and mental symptoms that developed after an initial COVID-19 infection and have been present for at least 3 months. 

If any of the exclusion criteria below are met, you will not be suitable for participation in this study:

1. You currently have a COVID-19 infection
2. You suffer from a serious medical condition including but not limited to cancer, type 1 diabetes, kidney disease, heart failure, chronic obstructive pulmonary disease, or autoimmune disease,
3. You suffer from an unstable medical condition (other than long COVID) that has required recent hospitalisation or treatment changes within the last 3 months, or there will be a requirement for treatment changes during the study period.
4. You are pregnant, breastfeeding, or intend to fall pregnant in the next 3 months
5. In the last 30 days, you have received, or intend to receive during the study period, a COVID-19 vaccine or booster or any other treatment for active/long COVID
6. You have received any blood, plasma products or immunoglobulins within the past 60 days or intend to do so during the study period.
7. You have received any immunosuppressive treatments within the past 90 days or intend to do so during the study period.
8. In the last 3 months, you have taken part in another interventional study or intend to do so during the study
9. You have any surgery or treatments scheduled during the study period that, in the opinion of the researcher, may compromise adherence to the study
10. You have a history of allergic reactions or hypersensitivity to the ingredients in the experimental product or placebo.
11. Your currently smoke or have been a heavy smoker within the last 3 years
12. You have a history of excessive alcohol consumption and/or drug abuse in the last 12 months

This study has been approved by the National Institute of Integrative Medicine (NIIM) Ethics Committee (Reference number: 0116E_2022)

If you are interested in participating in this study, click on the button below to complete the initial screening questionnaire. This questionnaire will take 10 minutes to complete and helps us assess your eligibility to participate in this study.

Please Note: All answers are confidential and will only be seen by study investigators. If you are not eligible to participate in this study, your records will be deleted immediately

Please Note: All answers are confidential and will only be seen by study investigators. If you are not eligible to participate in this study, your records will be deleted immediately